🇺🇸 FDA
Patent

US 11136334

Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione

granted A61PA61P35/00

Quick answer

US patent 11136334 (Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione) held by ACTUATE THERAPEUTICS INC. expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ACTUATE THERAPEUTICS INC.
Grant date
Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P35/00